Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Fortifying the Bone-Implant Interface Part 1: An In Vitro Evaluation of 3D-Printed and TPS Porous Surfaces.

MacBarb RF, Lindsey DP, Bahney CS, Woods SA, Wolfe ML, Yerby SA.

Int J Spine Surg. 2017 Jun 1;11:15. doi: 10.14444/4015. eCollection 2017.

2.

Community DECISIONS: stakeholder focused watershed planning.

Bosch D, Pease J, Wolfe ML, Zobel C, Osorio J, Cobb TD, Evanylo G.

J Environ Manage. 2012 Dec 15;112:226-32. doi: 10.1016/j.jenvman.2012.07.031. Epub 2012 Aug 30.

PMID:
22940121
3.

Detection and quantification of tricyclic antidepressants and other psychoactive drugs in urine by HPLC/MS/MS for pain management compliance testing.

Poklis JL, Wolf CE, Goldstein A, Wolfe ML, Poklis A.

J Clin Lab Anal. 2012 Jul;26(4):286-94. doi: 10.1002/jcla.21519.

4.

Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism.

Diffenderfer MR, Brousseau ME, Millar JS, Barrett PH, Nartsupha C, Schaefer PM, Wolfe ML, Dolnikowski GG, Rader DJ, Schaefer EJ.

J Lipid Res. 2012 Jun;53(6):1190-9. doi: 10.1194/jlr.M019570. Epub 2012 Apr 2.

5.

Inflammation modulates human HDL composition and function in vivo.

de la Llera Moya M, McGillicuddy FC, Hinkle CC, Byrne M, Joshi MR, Nguyen V, Tabita-Martinez J, Wolfe ML, Badellino K, Pruscino L, Mehta NN, Asztalos BF, Reilly MP.

Atherosclerosis. 2012 Jun;222(2):390-4. doi: 10.1016/j.atherosclerosis.2012.02.032. Epub 2012 Feb 28.

6.

Mining the LIPG allelic spectrum reveals the contribution of rare and common regulatory variants to HDL cholesterol.

Khetarpal SA, Edmondson AC, Raghavan A, Neeli H, Jin W, Badellino KO, Demissie S, Manning AK, DerOhannessian SL, Wolfe ML, Cupples LA, Li M, Kathiresan S, Rader DJ.

PLoS Genet. 2011 Dec;7(12):e1002393. doi: 10.1371/journal.pgen.1002393. Epub 2011 Dec 8.

7.

Dense genotyping of candidate gene loci identifies variants associated with high-density lipoprotein cholesterol.

Edmondson AC, Braund PS, Stylianou IM, Khera AV, Nelson CP, Wolfe ML, Derohannessian SL, Keating BJ, Qu L, He J, Tobin MD, Tomaszewski M, Baumert J, Klopp N, Döring A, Thorand B, Li M, Reilly MP, Koenig W, Samani NJ, Rader DJ.

Circ Cardiovasc Genet. 2011 Apr;4(2):145-55. doi: 10.1161/CIRCGENETICS.110.957563. Epub 2011 Feb 8.

8.

Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL.

Millar JS, Ikewaki K, Bloedon LT, Wolfe ML, Szapary PO, Rader DJ.

J Lipid Res. 2011 Jan;52(1):136-42. doi: 10.1194/jlr.P008136. Epub 2010 Oct 22.

9.

Short-term treatment with high-dose atorvastatin reduces LDL cholesterol but shows no anti-inflammatory effects in normolipidemic subjects with normal CRP levels.

Millar JS, Ky B, Wolfe ML, Pruscino L, Baer A, Rader DJ.

Clin Transl Sci. 2010 Aug;3(4):140-6. doi: 10.1111/j.1752-8062.2010.00211.x.

11.

Lipoprotein(a) is strongly associated with coronary artery calcification in type-2 diabetic women.

Qasim AN, Martin SS, Mehta NN, Wolfe ML, Park J, Schwartz S, Schutta M, Iqbal N, Reilly MP.

Int J Cardiol. 2011 Jul 1;150(1):17-21. doi: 10.1016/j.ijcard.2010.02.021. Epub 2010 Mar 19.

12.

Inflammation induces fibrinogen nitration in experimental human endotoxemia.

Heffron SP, Parastatidis I, Cuchel M, Wolfe ML, Tadesse MG, Mohler ER 3rd, Ischiropoulos H, Rader DJ, Reilly MP.

Free Radic Biol Med. 2009 Oct 15;47(8):1140-6. doi: 10.1016/j.freeradbiomed.2009.07.025. Epub 2009 Jul 22.

13.

Evaluating the association between all components of the metabolic syndrome and pre-eclampsia.

Srinivas SK, Sammel MD, Bastek J, Ofori E, Andrela CM, Wolfe ML, Reilly M, Elovitz MA.

J Matern Fetal Neonatal Med. 2009 Jun;22(6):501-9. doi: 10.1080/14767050902794642.

PMID:
19479639
14.

A naturally occurring variant of endothelial lipase associated with elevated HDL exhibits impaired synthesis.

Brown RJ, Edmondson AC, Griffon N, Hill TB, Fuki IV, Badellino KO, Li M, Wolfe ML, Reilly MP, Rader DJ.

J Lipid Res. 2009 Sep;50(9):1910-6. doi: 10.1194/jlr.P900020-JLR200. Epub 2009 May 3.

15.

Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy.

Airan-Javia SL, Wolf RL, Wolfe ML, Tadesse M, Mohler E, Reilly MP.

Am Heart J. 2009 Apr;157(4):687.e1-8. doi: 10.1016/j.ahj.2009.01.001. Epub 2009 Feb 23.

16.

Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans.

Edmondson AC, Brown RJ, Kathiresan S, Cupples LA, Demissie S, Manning AK, Jensen MK, Rimm EB, Wang J, Rodrigues A, Bamba V, Khetarpal SA, Wolfe ML, Derohannessian S, Li M, Reilly MP, Aberle J, Evans D, Hegele RA, Rader DJ.

J Clin Invest. 2009 Apr;119(4):1042-50. doi: 10.1172/JCI37176. Epub 2009 Mar 16.

17.

Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism.

Brousseau ME, Millar JS, Diffenderfer MR, Nartsupha C, Asztalos BF, Wolfe ML, Mancuso JP, Digenio AG, Rader DJ, Schaefer EJ.

J Lipid Res. 2009 Jul;50(7):1456-62. doi: 10.1194/jlr.P800037-JLR200. Epub 2009 Feb 3.

18.

Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome.

Millar JS, Duffy D, Gadi R, Bloedon LT, Dunbar RL, Wolfe ML, Movva R, Shah A, Fuki IV, McCoy M, Harris CJ, Wang MD, Howey DC, Rader DJ.

Arterioscler Thromb Vasc Biol. 2009 Jan;29(1):140-6. doi: 10.1161/ATVBAHA.108.171223. Epub 2008 Nov 6.

19.

Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic Caucasians.

Qasim AN, Metkus TS, Tadesse M, Lehrke M, Restine S, Wolfe ML, Hannenhalli S, Cappola T, Rader DJ, Reilly MP.

Clin Endocrinol (Oxf). 2009 May;70(5):698-705. doi: 10.1111/j.1365-2265.2008.03375.x. Epub 2008 Aug 15.

20.

Adipokines, insulin resistance, and coronary artery calcification.

Qasim A, Mehta NN, Tadesse MG, Wolfe ML, Rhodes T, Girman C, Reilly MP.

J Am Coll Cardiol. 2008 Jul 15;52(3):231-6. doi: 10.1016/j.jacc.2008.04.016.

21.

Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor: in vitro and in vivo activity.

Acker BA, Jacobsen EJ, Rogers BN, Wishka DG, Reitz SC, Piotrowski DW, Myers JK, Wolfe ML, Groppi VE, Thornburgh BA, Tinholt PM, Walters RR, Olson BA, Fitzgerald L, Staton BA, Raub TJ, Krause M, Li KS, Hoffmann WE, Hajos M, Hurst RS, Walker DP.

Bioorg Med Chem Lett. 2008 Jun 15;18(12):3611-5. doi: 10.1016/j.bmcl.2008.04.070. Epub 2008 May 1.

PMID:
18490160
22.

The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.

Ky B, Burke A, Tsimikas S, Wolfe ML, Tadesse MG, Szapary PO, Witztum JL, FitzGerald GA, Rader DJ.

J Am Coll Cardiol. 2008 Apr 29;51(17):1653-62. doi: 10.1016/j.jacc.2008.01.026.

23.

Endothelial lipase is increased in vivo by inflammation in humans.

Badellino KO, Wolfe ML, Reilly MP, Rader DJ.

Circulation. 2008 Feb 5;117(5):678-85. doi: 10.1161/CIRCULATIONAHA.107.707349. Epub 2008 Jan 22.

PMID:
18212282
24.

Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism.

Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Cohn JS, Wilson A, Wolfe ML, Nartsupha C, Schaefer PM, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ.

J Lipid Res. 2008 Mar;49(3):543-9. Epub 2007 Nov 21.

25.

Plasma cytokines, metabolic syndrome, and atherosclerosis in humans.

Reilly MP, Rohatgi A, McMahon K, Wolfe ML, Pinto SC, Rhodes T, Girman C, Rader DJ.

J Investig Med. 2007 Jan;55(1):26-35.

PMID:
17441409
26.

Value of electrocardiographic and ankle-brachial index abnormalities for prediction of coronary atherosclerosis in asymptomatic subjects with type 2 diabetes mellitus.

Bagheri R, Schutta M, Cumaranatunge RG, Wolfe ML, Terembula K, Hoffman B, Schwartz S, Kimmel SE, Farouk S, Iqbal N, Reilly MP.

Am J Cardiol. 2007 Apr 1;99(7):951-5. Epub 2007 Feb 14.

PMID:
17398190
27.

Innate immunity modulates adipokines in humans.

Anderson PD, Mehta NN, Wolfe ML, Hinkle CC, Pruscino L, Comiskey LL, Tabita-Martinez J, Sellers KF, Rickels MR, Ahima RS, Reilly MP.

J Clin Endocrinol Metab. 2007 Jun;92(6):2272-9. Epub 2007 Mar 20.

PMID:
17374708
28.

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.

Cuchel M, Bloedon LT, Szapary PO, Kolansky DM, Wolfe ML, Sarkis A, Millar JS, Ikewaki K, Siegelman ES, Gregg RE, Rader DJ.

N Engl J Med. 2007 Jan 11;356(2):148-56.

PMID:
17215532
29.

Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonists.

Walker DP, Wishka DG, Piotrowski DW, Jia S, Reitz SC, Yates KM, Myers JK, Vetman TN, Margolis BJ, Jacobsen EJ, Acker BA, Groppi VE, Wolfe ML, Thornburgh BA, Tinholt PM, Cortes-Burgos LA, Walters RR, Hester MR, Seest EP, Dolak LA, Han F, Olson BA, Fitzgerald L, Staton BA, Raub TJ, Hajos M, Hoffmann WE, Li KS, Higdon NR, Wall TM, Hurst RS, Wong EH, Rogers BN.

Bioorg Med Chem. 2006 Dec 15;14(24):8219-48. Epub 2006 Oct 2.

PMID:
17011782
30.

Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.

Wishka DG, Walker DP, Yates KM, Reitz SC, Jia S, Myers JK, Olson KL, Jacobsen EJ, Wolfe ML, Groppi VE, Hanchar AJ, Thornburgh BA, Cortes-Burgos LA, Wong EH, Staton BA, Raub TJ, Higdon NR, Wall TM, Hurst RS, Walters RR, Hoffmann WE, Hajos M, Franklin S, Carey G, Gold LH, Cook KK, Sands SB, Zhao SX, Soglia JR, Kalgutkar AS, Arneric SP, Rogers BN.

J Med Chem. 2006 Jul 13;49(14):4425-36.

PMID:
16821801
31.

Reducing phosphorus runoff from dairy farms.

Bosch DJ, Wolfe ML, Knowlton KF.

J Environ Qual. 2006 Apr 26;35(3):918-27. Print 2006 May-Jun.

PMID:
16641330
32.

Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.

Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ.

Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1350-6. Epub 2006 Mar 30.

PMID:
16574893
33.

Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.

Foulkes AS, Wohl DA, Frank I, Puleo E, Restine S, Wolfe ML, Dube MP, Tebas P, Reilly MP.

PLoS Med. 2006 Mar;3(3):e52.

34.

Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome.

Samaha FF, Szapary PO, Iqbal N, Williams MM, Bloedon LT, Kochar A, Wolfe ML, Rader DJ.

Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):624-30. Epub 2005 Dec 15.

PMID:
16357312
35.

Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis.

Badellino KO, Wolfe ML, Reilly MP, Rader DJ.

PLoS Med. 2006 Feb;3(2):e22. Epub 2005 Dec 20.

36.

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome.

Szapary PO, Bloedon LT, Samaha FF, Duffy D, Wolfe ML, Soffer D, Reilly MP, Chittams J, Rader DJ.

Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):182-8. Epub 2005 Nov 10.

PMID:
16284192
37.

A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction.

Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U, Gudbjartsson DF, Gretarsdottir S, Magnusson KP, Gudmundsson G, Hicks A, Jonsson T, Grant SF, Sainz J, O'Brien SJ, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Levey AI, Abramson JL, Reilly MP, Vaccarino V, Wolfe ML, Gudnason V, Quyyumi AA, Topol EJ, Rader DJ, Thorgeirsson G, Gulcher JR, Hakonarson H, Kong A, Stefansson K.

Nat Genet. 2006 Jan;38(1):68-74. Epub 2005 Nov 10.

PMID:
16282974
38.

Higher order lipase gene association with plasma triglycerides.

Reilly MP, Foulkes AS, Wolfe ML, Rader DJ.

J Lipid Res. 2005 Sep;46(9):1914-22. Epub 2005 Jun 16.

39.

An ultrasonic device for source to skin surface distance measurement in patient setup.

Feng Y, Allison R, Hu XH, Mota H, Jenkins T, Wolfe ML, Sibata C.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1587-9.

PMID:
15817366
40.

Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.

Brousseau ME, Diffenderfer MR, Millar JS, Nartsupha C, Asztalos BF, Welty FK, Wolfe ML, Rudling M, Björkhem I, Angelin B, Mancuso JP, Digenio AG, Rader DJ, Schaefer EJ.

Arterioscler Thromb Vasc Biol. 2005 May;25(5):1057-64. Epub 2005 Mar 10.

41.

Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors.

Bodnar AL, Cortes-Burgos LA, Cook KK, Dinh DM, Groppi VE, Hajos M, Higdon NR, Hoffmann WE, Hurst RS, Myers JK, Rogers BN, Wall TM, Wolfe ML, Wong E.

J Med Chem. 2005 Feb 24;48(4):905-8.

PMID:
15715459
42.

Resistin is an inflammatory marker of atherosclerosis in humans.

Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ.

Circulation. 2005 Feb 22;111(7):932-9. Epub 2005 Feb 14.

PMID:
15710760
43.

Intercellular adhesion molecule 1 (ICAM-1) gene variant is associated with coronary artery calcification independent of soluble ICAM-1 levels.

Reilly MP, Wolfe ML, Dykhouse J, Reddy K, Localio AR, Rader DJ.

J Investig Med. 2004 Dec;52(8):515-22. doi: 10.1136/jim-52-08-23.

PMID:
15682683
44.

The WalkAbout: A new solution for preventing falls in the elderly and disabled.

Wolfe RR, Jordan D, Wolfe ML.

Arch Phys Med Rehabil. 2004 Dec;85(12):2067-9.

PMID:
15605350
45.

Cholesteryl ester transfer protein and coronary artery disease: an observation with therapeutic implications.

Wolfe ML, Rader DJ.

Circulation. 2004 Sep 14;110(11):1338-40. No abstract available.

PMID:
15364817
46.

Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes.

Reilly MP, Iqbal N, Schutta M, Wolfe ML, Scally M, Localio AR, Rader DJ, Kimmel SE.

J Clin Endocrinol Metab. 2004 Aug;89(8):3872-8.

PMID:
15292320
47.

Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis.

Reilly MP, Wolfe ML, Rhodes T, Girman C, Mehta N, Rader DJ.

Circulation. 2004 Aug 17;110(7):803-9. Epub 2004 Aug 2.

PMID:
15289378
48.

Coronary artery calcification and cardiovascular risk factors: impact of the analytic approach.

Reilly MP, Wolfe ML, Localio AR, Rader DJ.

Atherosclerosis. 2004 Mar;173(1):69-78.

PMID:
15177125
49.

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.

Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ.

N Engl J Med. 2004 Apr 8;350(15):1505-15.

PMID:
15071125
50.

A high-throughput resonance energy transfer assay for Staphylococcus aureus DNA ligase.

Benson EL, Tomich PK, Wolfe ML, Choi GH, Hagadorn JC, Mutchler VT, Garlick RL.

Anal Biochem. 2004 Jan 15;324(2):298-300. No abstract available.

PMID:
14690695

Supplemental Content

Loading ...
Support Center